Porter, Kholoud - Resultats de la cerca - Dipòsit Digital de Documents de la UAB

Cerca col·leccions:

Ordena'ls per:	Mostrar els resultats:	Format de visualizació:

Resultats globals: 4 registres trobats en 0.50 segons.
Articles, 4 registres trobats

Articles	4 registres trobats

9 p, 319.8 KB

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death / Olson, Ashley D. (Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom) ; Walker, A. Sarah (Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom) ; Suthar, Amitabh B. (South African Centre for Epidemiological Modelling and Analysis, University of Stellenbosch, South Africa) ; Sabin, Caroline A. (Department of Infection and Population Health, University College London (UCL), London, United Kingdom) ; Bucher, Heiner (University Hospital Basel (Basilea, Suïssa)) ; Jarrín, Inmaculada (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Moreno, Santiago (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Pérez-Hoyos, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Porter, Kholoud (Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom) ; Ford, Deborah (Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom) ; Universitat Autònoma de Barcelona
Supplemental Digital Content is Available in the Text. Viremia copy-years (VCY), a time-updated measure of cumulative HIV exposure, predicts AIDS/death; although its utility in deciding when to start combination antiretroviral therapy (cART) remains unclear. [...]
2016 - DOI (Digital Object Identifier)

10.1097/QAI.0000000000001029
Journal of acquired immune deficiency syndromes (1999), Vol. 73 (august 2016) , p. 100-108

Registre complet -

11 p, 679.0 KB

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved? / Jarrin, Inma (Instituto de Salud Carlos III) ; Pantazis, Nikos (Athens University Medical School, Athens, Greece) ; Dalmau, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Phillips, Andrew N. (Research Department of Infection and Population Health) ; Olson, Ashley (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Mussini, Cristina (Institute of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy) ; Boufassa, Faroudy (Univ Paris-Sud, Le Kremlim Bicetre) ; Costagliola, Dominique (INSERM, Paris, France) ; Porter, Kholoud (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Blanco, Julià (Universitat de Vic - Universitat Central de Catalunya) ; Del Amo, Julia (Instituto de Salud Carlos III) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
This article compares trends in CD4 + T-cell recovery and proportions achieving optimal restoration (≥500 cells/μl) after viral suppression following combination antiretroviral therapy (cART) initiation between rapid and nonrapid progressors. [...]
2015 - DOI (Digital Object Identifier)

10.1097/QAD.0000000000000805
AIDS, Vol. 29 (october 2015) , p. 2323-2333

Registre complet -

7 p, 215.9 KB

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype / Olson, Ashley D. (University College London. Medical Research Council Clinical Trials Unit (United Kingdom)) ; Guiguet, Marguerite (Université Pierre et Marie Curie (France)) ; Zangerle, Robert (Innsbruck Medical University (Austria)) ; Gill, John (University of Calgary (Canada)) ; Pérez-Hoyos, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lodi, Sara (Instituto de Salud Carlos III) ; Ghosn, Jade (CHU Bicêtre. Service de Médecine Interne et Maladies Infectieuses (France)) ; Dorrucci, Maria (Istituto Superiore di Sanità (Italy)) ; Johnson, Anne (University College London. Institute of Epidemiology and Health Care (United Kingdom)) ; Sannes, Mette (Ulleval University Hospital (Norway)) ; Moreno, Santiago (Hospital Universitario Ramón y Cajal (Madrid)) ; Porter, Kholoud (University College London. Medical Research Council Clinical Trials Unit (United Kingdom)) ; Universitat Autònoma de Barcelona
Supplemental Digital Content is Available in the Text. Rapid CD4 cell loss represents an HIV phenotype used to identify causal variants of accelerated disease progression. The optimal rate and threshold for identifying this extreme phenotype in recently infected individuals is unclear. [...]
2014 - DOI (Digital Object Identifier)

10.1097/QAI.0000000000000240
Journal of acquired immune deficiency syndromes (1999), Vol. 67, Issue 1 (September 2014) , p. 15-21

Registre complet -

10 p, 194.9 KB

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014 / Simmons, Ruth (University College London) ; Malyuta, Ruslan (Perinatal Prevention of AIDS Initiative (Odessa, Ukraïna)) ; Chentsova, Nelli (Kyiv City AIDS Center (Kyiv, Ukraïna)) ; Medoeva, Antonia (Kyiv City AIDS Center (Kyiv, Ukraïna)) ; Kruglov, Yuri (Institute of Epidemiology (Kyiv, Ukraïna)) ; Yurchenko, Alexander (Kyiv City AIDS Center (Kyiv, Ukraïna)) ; Copas, Andrew (University College London) ; Porter, Kholoud (University College London) ; CASCADE Collaboration in EuroCoord
Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. [...]
2015 - DOI (Digital Object Identifier)

10.1371/journal.pone.0137062
PloS one, Vol. 10 Núm. 8 (august 2015)

Registre complet -

Vegeu també: autors amb noms similars
1	Porter, Keshia M. Pollack

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.